Skip to main content
. 2024 Feb 16;16(2):72–82. doi: 10.4253/wjge.v16.i2.72

Table 3.

Incidence of hospitalization costs and salvage treatments after recurrence or metastasis before inverse probability of treatment weighting adjustment

Parameter
ESD, n = 98
Surgery, n = 220
d-CRT, n = 16
Follow up time 40.0 (35.0-48.0) 43.0 (34.0-53.75) 32.5 (28.3-40.0)
Total cost 25 100 130
Death toll 1 (1.0) 19 (8.6) 3 (18.8)
Recurrence 4 (4.0) 3 8(17.3) 4 (25.0)
Salvage measures after recurrence or metastasis Surgery (n = 3) Surgery (n = 5) Neoadjuvant chemo-radiotherapy (n = 1)
No treatment (n = 1) Neoadjuvant radiotherapy (n = 4)
Neoadjuvant chemotherapy (n = 8)
Neoadjuvant chemo-radiotherapy (n = 15)
No treatment (n = 7)

Data are n (%). d-CRT: Definitive chemoradiotherapy; ESD: Endoscopic submucosal dissection.